Cancer / Immunology
The Asia-Pacific region is growing in importance in the global healthcare sector and this new subsidiary will serve as a focus for eTheRNA’s increasi...
August 03, 2021 | News
Clarity's Executive Chairman, Dr Alan Taylor, commented, "The prostate cancer market is a key focus for Clarity and we are very pleased to commence th...
July 29, 2021 | News
Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, pro...
July 28, 2021 | News
Elekta announced that GenesisCare, a leading global provider of integrated cancer care, has ordered 27 Flexitron® brachytherapy afterlo...
July 25, 2021 | News
Presentation of 36 abstracts underscore the potential of Elekta Unity to advance precision radiation medicine Elekta (EKTA-B.ST) today announced the prese...
July 23, 2021 | News
Magnetic field can be used to stimulate blood vessel growth, according to a study published in the journal Science and Technology of Advanced Materials. Th...
July 22, 2021 | News
Thermo Fisher Scientific today announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant cl...
July 20, 2021 | News
It makes Konyang University Hospital the first facility in South Korea to use MH Guide. "Precision medicine in cancer care enables personalized treat...
July 16, 2021 | News
Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to produce majo...
July 12, 2021 | News
MiRXES Pte Ltd, a biotechnology company focused on improving and saving lives with RNA-powered disease early detection tests, announced today it has ...
July 12, 2021 | News
For the last several years, Elekta (EKTA-B.ST) has invested substantially in digitized service solutions to keep critical treatment machines up and running...
July 07, 2021 | News
These antibodies have been functionally validated by the Pierre Fabre R&D teams for their specific properties on a pivotal immuno-oncology target actin...
July 06, 2021 | News
According to Globocan, in 2020 the global burden of cancer increased to 19.3 million new cases and 10 million deaths[1]. Worldwide, the most common type of...
July 06, 2021 | News
Frankfurt Prime Standard:QIA) today announced a global strategic alliance with Japan’s Sysmex Corporation (Tokyo Stock Exchange, First Section [Ticke...
July 02, 2021 | News
Most Read
Bio Jobs
News